Mounjaro and Perimenopause: What the Latest Data Shows About Weight Loss, Costs, and Market Impact
Finance
Mounjaro (tirzepatide) is approved for weight management and type 2 diabetes. In perimenopause, metabolic slowdown and hormonal shifts often drive weight gain. Clinical trials s...
Open article